S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis.

by Xiaolin Liu, Yongfeng Wang, Yanan Ming, Yanyan Song, Jingyi Zhang, Xiaoyu Chen, Minde Zeng, Yimin Mao
Published 2015-01-01

Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B.

by Jieyao Cheng, Jinlin Hou, Huiguo Ding, Guofeng Chen, Qing Xie, Yuming Wang, Minde Zeng, Xiaojuan Ou, Hong Ma, Jidong Jia
Published 2015-01-01

Exploring the efficacy and safety of polyene phosphatidylcholine for treatment of drug-induced liver injury using the Roussel Uclaf causality assessment method: a propensity score...

by Xiaohong Lei, Jianzhong Zhang, Qingling Xu, Jing Li, Yunsong Qian, Jing Zhang, Liangming Liu, Wei Zhong, Yongfeng Wang, Xian Han, Jieting Tang, Minde Zeng, Yimin Mao
Published 2021-08-01

Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial

by Jieting Tang, Yongfeng Wang, Tao Han, Qing Mao, Jun Cheng, Huiguo Ding, Jia Shang, Qin Zhang, Junqi Niu, Feng Ji, Chengwei Chen, Jidong Jia, Xiangjun Jiang, Nonghua Lv, Yueqiu Gao, Zhenghua Wang, Zhong Wei, Yingxuan Chen, Minde Zeng, Yimin Mao
Published 2020-11-01